MediFyr
NAHSV Healthlinko Private Limited today announced the completion of its first year of operations, marking a milestone defined by profitable growth, expanding patient impact and the early foundations of international scale through its flagship healthcare platform, MediFyr.
Founded in April 2025 with the goal of improving how patients access and navigate healthcare, the company has spent its first year building a technology-led model focused on accessibility, trust and sustainable growth. In that period, NAHSV Healthlinko has evolved from an early-stage venture into a growing digital health business with increasing market traction.
At the center of this progress has been MediFyr, which has emerged as the company’s principal growth engine. The platform currently supports more than 2,000 patients every month, helping users address medical needs through healthcare discovery, treatment coordination and patient support solutions.
Driven by growing adoption and operating momentum, the company recorded ₹65 lakh in revenue in the last quarter of the previous financial year, a milestone it says reflects both market demand and the scalability of its business model.
Notably, the company said this growth has been achieved without external investment, with NAHSV Healthlinko operating as a bootstrapped and profitable company throughout its first year. Management said this foundation has allowed the business to prioritize disciplined execution, strong fundamentals and long-term value creation.
“In year one, the focus was to build something sustainable, credible and scalable,” the company said in a statement. “The progress achieved through MediFyr has validated that foundation, and we now see significant opportunity ahead.”
Beyond MediFyr, the company has continued expanding a broader portfolio that includes Zerunio, WhatPregnant, HealthSetu and Unikorn, supporting a long-term strategy to build a connected ecosystem across healthcare and wellness.
As the company enters its second year, global expansion is expected to be a major growth driver. Through MediFyr, the company has already established partnerships and signed hospitals across Turkey, Egypt, Israel, Thailand, UAE and China, creating an early international network designed to support cross-border healthcare access and medical facilitation.
According to the company, these partnerships represent the beginning of a broader international growth strategy, positioning MediFyr to participate in rising demand for global healthcare connectivity.
NAHSV Healthlinko said the coming year will focus on converting this early foundation into scale — expanding patient reach, strengthening provider networks, investing in technology infrastructure and accelerating international growth.
Management said the combination of profitable execution, growing patient demand and international partnerships has positioned the company for a stronger second phase.
With one year completed, NAHSV Healthlinko said it views the milestone not as a culmination, but as the start of a broader opportunity to scale MediFyr and strengthen its role in healthcare access across markets.
About the Author
